Open access publisher BioMed Central, UK, has announced that DARU Journal of Pharmaceutical Sciences has published its inaugural articles with BioMed Central. Amongst these are an editorial by Editor-in-Chief Mohammad Abdollahi which highlights the need for a quality, open-access journal in the field of pharmaceutical sciences.
The launch articles also include original research on enhancing indomethacin release in vitro, and propylene glycol tolerance in neonates, as well as a review article on the status of lead pollution and toxicity in Iran.
DARU Journal of Pharmaceutical Sciences is published on behalf of Tehran University of Medical Sciences that encompasses all fields of the science related to pharmacy and drugs. The journal considers outstanding studies from basic research to clinical investigations as original articles, systematic reviews, meta-analyses, general reviews, mini-reviews, short communications, and editorials from the global scientific community.
